Make More Lentivirus And Make It Right The First Time
Source: MilliporeSigma
Achieve higher titers and robust yield with an optimized, comprehensive lentivirus platform, designed to maximize production and quality for your cell or gene therapy's success. Experience faster development timelines and reduced manufacturing risks, and achieve the high performance and product quality required for clinical trials, all while delivering a lower cost per therapeutic dose. Watch this webinar to discover how the VirusExpress® lentivirus platform enables clinical and commercial success.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more